Back to search

Article

Comparative evaluation of synthetic cytokines for enhancing production and performance of NK92 cell-based therapies

2023-05-14

Abstract excerpt

Autologous immune cell therapies are potentially curative, but cost and manufacturing complexity limit access. Off-the-shelf therapies may address these gaps, but further development is needed. The NK92 cell line has a natural killer-like phenotype, has efficacy in cancer clinical trials, and is safe after irradiation. However, NK92 lose activity post-injection, limiting efficacy. This may be addressed by engineer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
976c1e72-eedf-56fb-8b68-0726df9dcf56
DOI
10.1101/2023.05.13.540611
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative evaluation of synthetic cytokines for enhancing production and performance of NK92 cell-based therapiesDOI 10.1101/2023.05.13.540611
Select a neighboring publication to make it the new centre.